The SENS Research Foundation and the Forever Healthy Foundation have joined forces to host an exciting conference about rejuvenation biotechnology on March 15-17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany.

A conference for everyone

The conference is open to the wider community interested in this field and anyone can attend. We believe that this is a fantastic move, as it allows more people to engage with the science and to learn firsthand from the researchers working on the front line. We very much support the idea that we are all in this together and thus are delighted to see that the event is open to the entire community.

This event will be a fantastic opportunity to network and learn about the latest exciting innovations and progress in the field. The strength of our community relies on our ability to network effectively and engage with the wider public audience as well as attract the support of investors and philanthropists.

We are also delighted to tell you that the team will be there in full force. Our President Keith Comito, Vice President Oliver Medvedik, Outreach Director Elena Milova, Content and Social Media Director Steve Hill, and Board Director Paul Spiegel will all be at the conference. This is an exciting opportunity for us too, as due to us being an international team, the chance to meet up in person is rare, and we are excited to be there together.

We will be bringing you lots of news, interviews, and other highlights, both during and after the event. We will have the chance to speak with the leading scientists in the field and will make sure that you are the first to know what is happening in the world of rejuvenation biotechnology.

We would like to thank our supporters, including those who have donated to projects as well as our monthly patrons, the Lifespan Heroes, and those of you who made a single donation, too! Without you, we would not be at the show reporting on the latest developments and keeping the community informed. We really do appreciate your kind support and will be working hard to bring you the best in biotech news; thank you.

On the cusp of great changes in medicine

This conference comes at an ideal time, as the first true, repair-based rejuvenation therapies are starting to enter human clinical trials now and will arrive in the near future. The meteoric rise of interest in senescent cell-clearing therapies, known as senolytics, is one example of how the first rejuvenation technologies are at our doorstep. Senolytics are poised to enter human clinical trials this year with Unity Biotechnology after a decade of solid research and progress, and Mayo Clinic is not far behind in launching more trials. Several other groups, such as Oisin, are hot on their heels, developing more refined ways to remove senescent cells.

Researchers are also making progress on gene therapies, gene editing, DNA repair, stem cell therapies and tissue engineering, all of which can also be used to directly address aging processes, allowing for healthier and longer lives.

However, this is not all we are going to talk to the researchers about. Our world is changing every day, and the rejuvenation biotechnology industry will change accordingly. For example, not long ago, the SRF received a generous donation from Vitalik Buterin, the creator of the cryptocurrency Ethereum. His donation, worth $2.4 million, is the first of its kind but hopefully not the last. We are going to ask the attendees how they feel about the role of cryptocurrencies and related phenomena, such as initial coin offerings, in the further development of rejuvenation biotechnology. You may already know that has been accepting donations in bitcoin from very early on as well, and we are keeping an eye on how it might make crowdfunding for research on aging more successful.


We truly stand on the threshold of radical changes in medicine and how we see aging, and this conference is perfectly timed to harness the rising enthusiasm for therapies that target aging processes themselves to eradicate age-related diseases.

For more details about the conference, visit the website here.


About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:


Your email address will not be published.

Privacy Policy / Terms Of Use

       Powered by MMD